We've found
21,509 Breast Cancer
clinical trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
AVID100 in Advanced Epithelial Carcinomas
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Single Patient, Compassionate Use of MARGETUXIMAB for the Treatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 4/27/2017
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer Clinical Trial
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
21,509 Breast Cancer
clinical trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Node Positive HER2 Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
AVID100 in Advanced Epithelial Carcinomas
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 4/27/2017
Single Patient, Compassionate Use of MARGETUXIMAB for the Treatment of HER2+ Metastatic Breast Cancer
Status: Enrolling
Updated: 4/27/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Carcinoma Clinical Trial
Updated: 12/31/1969
Breast Cancer WEight Loss Study (BWEL Study)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials